National manufacturer of
immunobiological products in Russia
En
National manufacturer of
immunobiological products in Russia

News

  • New productions to be created at Microgen

    04.06.2021

    Pharmaceutical holding Nacimbio of Rostec State Corporation will create new production facilities at NPO Microgen subsidiaries in Ufa, Perm and Tomsk.

    Read more
  • Relatox® entered the Uzbek market

    01.06.2021

    Microgen-developed drug Relatox® became available for Uzbek patients.

    Read more
  • Microgen increases the export of pharmaceuticals to Uzbekistan

    20.05.2021

    In the first quarter of 2021, Scientific and Production Association Microgen increased exports of drug products to Uzbekistan by over 50 percent as compared to the same period of the last year.

    Read more
  • NPO Microgen and National Association of the Specialists in Infections Control agreed to pool efforts in vaccination popularization area

    26.04.2021

    In April 2021, a partnership agreement between NPO Microgen and NASKI (National Association of the Specialists in Control of Infections) was signed for raising awareness among the Russian Federation population of the benefits of preventive vaccination.

    Read more
  • Perm subsidiary of NPO Microgen to expand the production of vaccines and blood products

    15.04.2021

    Within the partnership, a new vaccine production will be opened and release of blood plasma-based drugs including COVID-globulin for the coronavirus infection treatment will be arranged in Perm.

    Read more
  • Microgen obtained registration for the new vaccine

    09.02.2021

    Microgen announced the registration of bivalent polysaccharide vaccine for the prevention of meningococcal infection by the Ministry of Health of the Russian Federation.

    Read more